Role of Pelvic Lymphadenectomy in the Treatment of Bladder Cancer: A Mini Review

다국어 초록 (Multilingual Abstract)

Although radical cystectomy with pelvic lymph node dissection (PLND) is the standard treatment for muscle-invasive bladder cancer, the optimal extent of PLND and the minimum number of nodes that should be examined for pathology remain unclear. However, evidence is growing that extended PLND has additional diagnostic and therapeutic benefits relative to standard PLND. In particular, a more meticulous and extended PLND may improve the disease-free survival of node-negative patients because it removes undetected micrometastases. Indeed, some patients with positive nodes can be cured by surgery alone, even those with gross adenopathy. Increasing lines of evidence also suggest that the extent of the primary bladder tumor, the number of lymph nodes that are removed, and the lymph node tumor burden are important prognostic variables in patients undergoing cystectomy. Therefore, extended PLND may not only provide improved prognostic information, it may also have a clinically significant therapeutic benefit for both lymph node-positive and node-negative patients undergoing radical cystectomy. Although the absolute limits of PLND remain to be determined, evidence supports the notion that a more extended PLND should include the common iliac vessels and presacral lymph nodes at cystectomy. Such PLND should only be performed in patients who are appropriate surgical candidates. Prospective, randomized trials are needed to properly establish the extent of PLND that is required to generate these benefits

참고문헌 (Reference)

1 Hellenthal NJ, "Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004" 181 : 2490-2495, 2009

2 Prout GR, "The prognosis with untreated bladder tumors" 9 : 551-558, 1956

3 Wright JL, "The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy" 112 : 2401-2408, 2008

4 Herr HW, "Surgical factors influence bladder cancer outcomes: a cooperative group report" 22 : 2781-2789, 2004

5 Herr HW, "Superiority of ratio based lymph node staging for bladder cancer" 169 : 943-945, 2003

6 Koppie TM, "Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed?" 107 : 2368-2374, 2006

7 Vazina A, "Stage specific lymph node metastasis mapping in radical cystectomy specimens" 171 : 1830-1834, 2004

8 Crawford ED, "Salvage cystectomy after irradiation failure" 123 : 32-34, 1980

9 Osawa T, "Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study" 16 : 274-278, 2009

10 Stein JP, "Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density" 170 : 35-41, 2003

11 Gaitonde K, "Retrospective review and long-term follow-up of radical cystectomy in a developing country" 89 (89): 57-61, 2002

12 Honma I, "Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer--analysis of role of pelvic lymph node dissection" 68 : 543-548, 2006

13 Smith JA, "Regional lymph node metastasis from bladder cancer" 126 : 591-593, 1981

14 Poulsen AL, "Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall" 160 : 2015-2019, 1998

15 Stein JP, "Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer" 177 : 876-881, 2007

16 Stein JP, "Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients" 19 : 666-675, 2001

17 Ghoneim MA, "Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases" 158 : 393-399, 1997

18 Ghoneim MA, "Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later" 180 : 121-127, 2008

19 Madersbacher S, "Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy" 21 : 690-696, 2003

20 Steven K, "Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only" 178 : 1218-1223, 2007

21 Bochner BH, "Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping" 172 : 1286-1290, 2004

22 Fleischmann A, "Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder" 29 : 89-95, 2005

23 Bassi P, "Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort" 161 : 1494-1497, 1999

24 Seiler R, "Pelvic lymph nodes: distribution and nodal tumour burden of urothelial bladder cancer" 63 : 504-507, 2010

25 Mills RD, "Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy" 166 : 19-23, 2001

26 Vieweg K, "Pelvic lymph node dissection can be curative in patients with node positive bladder cancer" 161 : 449-454, 1999

27 Shariat SF, "Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium" 176 : 2414-2422, 2006

28 Herr HW, "Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy" 165 : 62-64, 2001

29 Dhar NB, "Outcome after radical cystectomy with limited or extended pelvic lymph node dissection" 179 : 873-878, 2008

30 Abdel-Latif M, "Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis" 172 : 85-89, 2004

31 Skinner DG, "Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference" 128 : 34-36, 1982

32 Leissner J, "Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis" 85 : 817-823, 2000

33 Stein JP, "Lymphadenectomy for invasive bladder cancer. II. technical aspects and prognostic factors" 97 : 232-237, 2006

34 Jensen JB, "Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenteric artery"

35 Abol-Enein H, "Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study--a single center experience" 172 : 1818-1821, 2004

36 Kassouf W, "Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC" 26 : 121-126, 2008

37 Herr HW, "Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer" 167 : 1295-1298, 2002

38 Dangle PP, "How do commonly performed lymphadenectomy templates influence bladder cancer nodal stage?" 183 : 499-503, 2010

39 Hollenbeck BK, "Hospital lymph node counts and survival after radical cystectomy" 112 : 806-812, 2008

40 Fleischmann A, "Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor" 23 : 2358-2365, 2005

41 Konety BR, "Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base" 169 : 946-950, 2003

42 Leissner J, "Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study" 171 : 139-144, 2004

43 Kassouf W, "Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy" 176 : 53-57, 2006

44 Brossner C, "Does extended lymphadenectomy increase the morbidity of radical cystectomy?" 93 : 64-66, 2004

45 Gschwend JE, "Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy" 41 : 440-448, 2002

46 Hautmann RE, "Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era" 176 : 486-492, 2006

47 Jeong IG, "Comparison of 2002 TNM nodal status with lymph node density in node-positive patients after radical cystectomy for bladder cancer: analysis by the number of lymph nodes removed"

48 Bruins HM, "Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy" 182 : 2182-2187, 2009

49 Nishiyama H, "Clinical outcome of a large-scale multi-institutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during 1990-2000 in Japan" 45 : 176-181, 2004

50 Wiesner C, "Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node- positive bladder cancer: prediction by lymph node positivity and density" 104 : 331-335, 2009

51 Herr H, "Bladder Cancer Collaborative Group. Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report" 171 : 1823-1828, 2004

52 Stephenson AJ, "Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer" 75 : 382-386, 2010